An anti-peptic ulcer drug is a class of drugs used for the treatment of most common ulcers in stomach and upper part of small intestine. These drugs act by decreasing the levels of gastric acidity or by enhancing the protection for mucosa. Major causes of peptic ulcer are Helicobacter pylori (H. pylori) infection or due to long-term use of drugs such as aspirin, ibuprofen and non-steroidal anti-inflammatory drugs (NSAIDs).
Download Exclusive Sample of this Report: http://www.transparencymarketresearch.com/anti-peptic-ulcer-drugs.html
Anti-peptic ulcer drugs market is classified based on:
- Drug class
- Proton pump inhibitor
- H2 receptor antagonist
- Gastric mucosal protective drugs
At present, North America dominates the global anti-peptic ulcer drugs market and is followed by Europe. Anti-peptic ulcer drugs market growth in these regions is attributed to high incidence of people suffering from peptic ulcers and large number of patents expected to expire and thereby allowing entry of generics. Developing nations of Latin America such as Brazil, Argentina and Chile as well as Middle East Asian countries are expected to show rapid growth in demand for anti-peptic ulcer drugs due to poor sanitization and hygienic practices causing H. pylori infections in these regions. Higher incidence of peptic acid ulcers is boosting the production and marketing of anti-peptic ulcer drugs in Asia-Pacific regions such as India, China, and Australia.
Some of the key factors driving the market for anti-peptic ulcer drugs are increase in patient pool with H. pylori infection, stressed lifestyles, advances in peptic ulcer therapies and patent exclusivity expiration leading to decline in revenues and the resultant high generic competition.
Some of the key players contributing in anti-peptic ulcer market are AstraZeneca PLC, Daewoong Pharmaceutical Co., Ltd., Eisai Co., Ltd., HeliCure AB, Ore Pharmaceuticals, Inc., Sihuan Pharmaceutical Holdings Group Ltd. and Takeda Pharmaceutical Company Limited.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453